Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ADCT

ADC Therapeutics SA

Pharmaceutical Preparations · SIC 2834CIK 1771910Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$81.0M
Net Income FY2025
$(143.0M)
EPS (Basic, as reported)
$-1.12
Net Margin FY2025
-175.3%
ROE FY2025
76.7%
Total Equity
$(186.0M)
Shares Out
128M
Business description

ADC Therapeutics SA — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 75 → 81 +2.6% CAGR
Fiscal yearFY2022FY2023FY2024FY2025
Revenue75697181
Cost of revenue(3)(3)(6)(6)
Research & development(186)(127)(110)(104)
Selling & marketing(69)(57)(44)(43)
General & administrative(74)(48)(42)(37)
Total operating expenses(333)(236)(201)(203)
Operating income(123)(166)(131)(121)
Interest expense(37)(46)(50)(52)
Interest & investment income311129
Other income (expense), net(23)(29)(25)(20)
Pre-tax income(147)(195)(156)(142)
Income tax expense0(39)0(1)
Net income(157)(240)(158)(143)
EPS — basic($2.01)($2.94)($1.62)($1.12)
EPS — diluted($2.01)($2.94)($1.62)($1.12)
Shares outstanding — basic (M)788297127
Shares outstanding — diluted (M)788297127

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.